Service Introduction
Successful Cases
Team Advantage
Provide data management and statistical analysis services for domestic and foreign pharmaceuticals and life science related enterprises, provide targeted solutions according to project characteristics, support the acceleration of research and development progress, and provide excellent services that meet domestic and foreign standards.
● FDA/EMA/PMDA/NMPA filing:
Dacomitinib first-line treatment of locally advanced or metastatic NSCLC
harboring EGFR activating mutations
● FDA/EMA filing:
Enbrel biosimilar candidate SB4/Remicade biosimilar candidate SB2
● NMPA filing:
Fruquintinib for metastatic colorectal cancer
The educational background of the team includes biostatisticians with overseas background, Ph.D in health economics and Ph.D in medicine, etc. The core team has an average of more than 15 years of experience in the world's top 10 CROs and pharmaceutical companies. More than 300 clinical research experiences, covering multiple disease areas from Phase I to Phase IV, including tumor, cardiovascular, rheumatism and immunity, infectious diseases, etc. The Chinese team has rare international filing experience, including US FDA, European EMA, China NMPA, Japan PMDA, etc.
|
|
Tel：010-53681050